Status:
COMPLETED
Genetic Contribution of Pain and Inflammation in IBS
Lead Sponsor:
University of Florida
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
Brief Summary
The goal of the study is to identify possible polymorphisms on the loci of candidate genes that may be involved in modulation of pain and inflammation in irritable bowel syndrome.
Detailed Description
Stored and de-linked blood or DNA from subjects with IBS will be utilized for analysis for possible polymorphisms at predetermined genetic loci located in chosen genes.
Eligibility Criteria
Inclusion
- Subjects with IBS and previously stored samples
Exclusion
- Subjects without IBS and no previously stored samples
Key Trial Info
Start Date :
May 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT01436760
Start Date
May 1 2011
End Date
March 1 2012
Last Update
March 26 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32610